Development of molecularly targeted agents and immunotherapies in small cell lung cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Development of molecularly targeted agents and immunotherapies in small cell lung cancer

Published:2016-06 Issue: Volume:60 Page:26-39
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Sharp Adam,Bhosle Jaishree,Abdelraouf Fatma,Popat Sanjay^ORCID,O'Brien Mary,Yap Timothy A.

Funder

NIHR

Medical Research Council

British Lung Foundation

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference83 articles.

1. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012;Ferlay;Eur J Cancer,2013

2. Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database;Govindan;J Clin Oncol,2006

3. Gene mutations in small-cell lung cancer (SCLC): results of a panel of 6 genes in a cohort of Italian patients;Bordi;Lung Cancer,2014

4. Next-generation sequencing reveals frequent consistent genomic alterations in small cell undifferentiated lung cancer;Ross;J Clin Pathol,2014

5. Molecular profiling of small cell lung cancer in a Japanese cohort;Wakuda;Lung Cancer,2014

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genomic profiling of relapsed small cell lung cancer reveals potential pathways of therapeutic targets;Journal of Thoracic Disease;2023-12

2. Combined Immunotherapy and Targeted Therapies for Cancer Treatment: Recent Advances and Future Perspectives;Current Cancer Drug Targets;2023-04

3. Infiltrating T lymphocytes in the tumor microenvironment of small cell lung cancer: a state of knowledge review;Journal of Cancer Research and Clinical Oncology;2022-01-08

4. Profiling of DNA damage and repair pathways in small cell lung cancer reveals a suppressive role in the immune landscape;Molecular Cancer;2021-10-07

5. Risk of hypertension with anti-VEGF monoclonal antibodies in cancer patients: a systematic review and meta-analysis of 105 phase II/III randomized controlled trials;Journal of Chemotherapy;2021-07-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3